- Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
-
Lu T, Guo Q, Cui X, Chen Z, Lin S, Xu L, Lin J, Zong J, Pan J
- KMID: 2374113
- Yonsei Med J.
- 2016 Jul;57(4):840-845.
- doi: 10.3349/ymj.2016.57.4.840
PURPOSE: To evaluate the prognosis of nasopharyngeal carcinoma (NPC) patients who developed bone-only metastasis after primary treatment and the stratification of these patients into different risk groups based on independent... -
- CITED
-
- Close
- SHARE
-
- Close
- Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
-
Ji P, Lu Q, Chen X, Chen Y, Peng X, Chen Z, Lin C, Lin S, Zong J
- KMID: 2547786
- Cancer Res Treat.
- 2023 Oct;55(4):1113-1122.
- doi: 10.4143/crt.2022.1651
Purpose This retrospective study aimed to re-evaluate the effect of concurrent chemotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC) in the era of intensity-modulated radiotherapy (IMRT). Materials and Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationships between Islet-Specific Autoantibody Titers and the Clinical Characteristics of Patients with Diabetes Mellitus
-
Zhang Y, Yin T, Wang X, Zhang R, Yuan J, Sun Y, Zong J, Cui S, Gu Y
- KMID: 2516342
- Diabetes Metab J.
- 2021 May;45(3):404-416.
- doi: 10.4093/dmj.2019.0239
Background Dysimmunity plays a key role in diabetes, especially type 1 diabetes mellitus. Islet-specific autoantibodies (ISAs) have been used as diagnostic markers for different phenotypic classifications of diabetes. This study was... -
- CITED
-
- Close
- SHARE
-
- Close
